Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR).
- Disclosed ownership: 5.4%.
- Date of event: 27 Jun 2025.
INTEGRATED CORE STRATEGIES (US) LLC - 27 Jun 2025 SCHEDULE 13G Report for Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- NKTR
- Shares outstanding
- 17,275,241 shares
- Disclosed Ownership
- 932,863 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Jul 2025, 14:07:15 UTC
- Date of event
- 27 Jun 2025
- Next filing
- 28 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 5.4% ownership in Nektar Therapeutics Common Stock, par value $0.0001 per share (NKTR) on 27 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Jul 2025, 14:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 4.7% | 815,948 | 0 | 815,948 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 5.4% | 932,863 | 0 | 932,863 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 5.4% | 932,863 | 0 | 932,863 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 5.4% | 932,863 | 0 | 932,863 | /s/ Israel A. Englander | Israel A. Englander |